Press releases
FABENTECH is the only French SME chosen to be a part of the COUNTERACT European consortium, which aims to develop medical countermeasures targeting Chemical, Biological,
Lyon, 9 December 2021 – The EPIC-CROWN-2 project, initiated by the Lyon-based biotech company, has received funding to the tune
Phase I/II clinical trials in humans scheduled in 2021 Polyclonal antibodies are a safe, reproducible solution that is rapidly industrialisable at large scale thanks to Fab’entech’s new industrial site
Fab’entech, a French biotech specialised in the development and production of polyclonal antibodies, presents its new industrial site located in Saint-Priest, to the south-east of Lyon. The 1,000 m2 production site is now operational and will give Fab’entech the capacity to manufacture all of its innovations (biodefense and anti-COVID-19 programme: FabenCOV®) in France. Close-up of this new site, a key asset in the development of the biotech’s activities.
Sébastien Iva is the new Chief Executive Officer of Fab’entech, a Lyon-based biotech created in 2009 and specialised in the development and production of polyclonal antibodies intended for the treatment of emerging infectious diseases and the development of biodefense solutions. His mission is to ensure its development and transformation, with the stated objective of becoming a key player in the field of polyclonal antibodies. He took over from Bertrand Lépine, founder of Fab’entech, who now becomes a member of the Supervisory Council.
Lyon, dated 31 January 2020: Fab’entech, a Lyon-based biopharmaceutical company created in 2009 and specialised in immunotherapy for emergency situations,
Fab’entech, specialising in the treatment of emerging infectious diseases for 5 years, is offering passive anti-infective immunotherapy solutions based on specific and highly-purified polyclonal antibodies.
Fab’entech’s specific anti-H5N1 polyclonal antibodies could constitute a new approach in the treatment of H5N1 avian influenza in humans.
Agence Monet+Associés
Matthieu Mébarki – matthieu@monet-rp.com – 04 78 37 34 64
Mélanie Da Rui-Pons – mr@monet-rp.com – 06 58 98 85 75
